Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 430 Lymphoma, Large B-Cell, Diffuse 97 Leukemia, Lymphocytic, Chronic, B-Cell 88 Lymphoma, Follicular 81 Recurrence 72 Lymphoma 62 Lymphoma, Mantle-Cell 59 Neoplasms, Plasma Cell 58 Lymphoma, B-Cell, Marginal Zone 47 Lymphoma, Non-Hodgkin 46 Leukemia, Myeloid, Acute 34 Leukemia 32 Neoplasms 24 Myelodysplastic Syndromes 24 Lymphoma, B-Cell 24 Waldenstrom Macroglobulinemia 18 Hodgkin Disease 18 Smoldering Multiple Myeloma 17 Lymphoma, T-Cell, Peripheral 16 Burkitt Lymphoma 14 Hematologic Diseases 13 Lymphoma, T-Cell, Cutaneous 12 Lymphoma, T-Cell 12 Prostatic Neoplasms 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Sezary Syndrome 10 Mycosis Fungoides 10 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 9 Lymphoma, Large-Cell, Anaplastic 9 Leukemia, Myelomonocytic, Chronic 9

Interventions

Paclitaxel 4 liposomal doxorubicin 3 Carboplatin 3 pembrolizumab 2 Bevacizumab 2 1-dodecylpyridoxal 2 poly(I).poly(c12,U) 1 mirabegron 1 disitamab vedotin 1 apatinib 1 anlotinib 1 Tocotrienols 1 Platinum Compounds 1 Lenalidomide 1 Interferon alpha-2 1 Hyperthermic Intraperitoneal Chemotherapy 1 Gemcitabine 1 EP-100 membrane-disrupting peptide 1 Cisplatin 1 AC 7700 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Ovarian Cancer Recurrent × Lenalidomide × Clear all

NCT01111903 2016-03-17

REV

ARCAGY/ GINECO GROUP

Phase 1/2 Completed

Ovarian Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon ⚡